Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2013 | 1 |
2014 | 3 |
2015 | 1 |
2016 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
A critical question for HIV vaccine development: which antibodies to induce?
Science. 2014 Jul 11;345(6193):167-8. doi: 10.1126/science.1256526.
Science. 2014.
PMID: 25013066
Free PMC article.
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants.
Klein F, Nogueira L, Nishimura Y, Phad G, West AP Jr, Halper-Stromberg A, Horwitz JA, Gazumyan A, Liu C, Eisenreich TR, Lehmann C, Fätkenheuer G, Williams C, Shingai M, Martin MA, Bjorkman PJ, Seaman MS, Zolla-Pazner S, Karlsson Hedestam GB, Nussenzweig MC.
Klein F, et al.
J Exp Med. 2014 Nov 17;211(12):2361-72. doi: 10.1084/jem.20141050. Epub 2014 Nov 10.
J Exp Med. 2014.
PMID: 25385756
Free PMC article.
Item in Clipboard
Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity.
Zolla-Pazner S, Cohen SS, Boyd D, Kong XP, Seaman M, Nussenzweig M, Klein F, Overbaugh J, Totrov M.
Zolla-Pazner S, et al.
J Virol. 2015 Oct 21;90(2):636-49. doi: 10.1128/JVI.01645-15. Print 2016 Jan 15.
J Virol. 2015.
PMID: 26491157
Free PMC article.
Item in Clipboard
Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.
Edwards TG, Wyss S, Reeves JD, Zolla-Pazner S, Hoxie JA, Doms RW, Baribaud F.
Edwards TG, et al.
J Virol. 2002 Mar;76(6):2683-91. doi: 10.1128/jvi.76.6.2683-2691.2002.
J Virol. 2002.
PMID: 11861835
Free PMC article.
Item in Clipboard
Epitope mapping of conformational V2-specific anti-HIV human monoclonal antibodies reveals an immunodominant site in V2.
Mayr LM, Cohen S, Spurrier B, Kong XP, Zolla-Pazner S.
Mayr LM, et al.
PLoS One. 2013 Jul 29;8(7):e70859. doi: 10.1371/journal.pone.0070859. Print 2013.
PLoS One. 2013.
PMID: 23923028
Free PMC article.
Item in Clipboard
Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection.
Zolla-Pazner S, deCamp A, Gilbert PB, Williams C, Yates NL, Williams WT, Howington R, Fong Y, Morris DE, Soderberg KA, Irene C, Reichman C, Pinter A, Parks R, Pitisuttithum P, Kaewkungwal J, Rerks-Ngarm S, Nitayaphan S, Andrews C, O'Connell RJ, Yang ZY, Nabel GJ, Kim JH, Michael NL, Montefiori DC, Liao HX, Haynes BF, Tomaras GD.
Zolla-Pazner S, et al.
PLoS One. 2014 Feb 4;9(2):e87572. doi: 10.1371/journal.pone.0087572. eCollection 2014.
PLoS One. 2014.
PMID: 24504509
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite